Skip Ribbon Commands
Skip to main content
Dr Wong Yi Ting Evelyn

Dr Wong Yi Ting Evelyn

MBBS, MRCP (Edin), M Med (Internal Medicine), FAMS

Associate Consultant

Specialty: Medical Oncology

Sub-specialties: Colorectal, Hepato-Pancreato-Biliary, Liver, Upper Gastrointestinal

Conditions Treated by this Doctor:
Anal Cancers, Bile Duct Cancer, Biliary Tract Cancer, Colorectal Cancer, Gastrointestinal Stromal Tumour (GIST), Liver Cancer, Oesophagus Cancer, Pancreatic Cancer, Pancreatico-Biliary Diseases, Stomach Cancer.

Clinical Appointments

  • Associate Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore
  • Visiting Consultant Changi General HospitalChangi General Hospital
  • Visiting Consultant Sengkang General HospitalSengkang General Hospital

Academic Appointments

  • Clinical Instructor, Oncology ACP, SingHealth Duke-NUS Global Health Institute

Profile

Dr Evelyn Wong Yi Ting, MBBS (S’pore), MRCP (Edinburgh), MMED (S’pore), FAMS is an Medical Oncologist who practices at the National Cancer Centre Singapore and Sengkang General Hospital. Dr Wong's subspecialty interests includes upper gastrointestinal cancers, hepatobiliary cancers and lower gastrointestinal cancers. 

She completed her post-graduate certification with a Membership of the Royal College of Physicians (MRCP) (Edinburgh) and a Master of Medicine (Internal Medicine) (MMed) from the National University of Singapore. She completed her specialist training at National Cancer Centre Singapore. 

She founded AYABytes, a mobile app, co-created by patients and physicians, for Adolescents and Young Adults (AYA) cancer patients. Dr Wong also has an keen interest in health economics and health policy and works towards reducing disparities in cancer care globally. She participates actively in the global community, having worked with communities in Chennai (India), Kathmandu (Nepal), Yunnan (China) and Mae Na Chon (Thailand). She was a founding member and Director of Seeds of Nations Pte Ltd (2013-2017), a corporation focused on global community projects. She is currently a Clinical Instructor, Oncology ACP, SingHealth Duke-NUS Global Health Institute. 

Dr Wong is also active in teaching Senior Residents, medical officers, and medical and nursing students. She has received accolades for her educational efforts including Residency in Singhealth Excels Inspiring Resident Educator Award 2020 and the NUS Yong Loo Lin School of Medicine Medical Society Outstanding Tutor Award 2018.

Education

  • Fellow of Academy of Medicine Singapore, Chapter of Medical Oncologists, College of Physicians, 2022
  • Member of Royal College of Physicians (Edinburgh); Master of Medicine (Internal Medicine) (Singa-pore), 2016
  • Bachelor of Medicine and Bachelor of Surgery (MBBS), 2014

Professional Appointments and Committee Memberships

  • Member, Proactive Care Workgroup, NCCS
  • Faculty Trainer, SingHealth Duke-NUS Global Health Institute

Awards

  • Residency in SingHealth Excels (RiSE) Awards, Inspiring Resident Educator Award 2020
  • NUS Dean Visit Award- Appreciate for Clinical Teachers, Special Recognition Award 2019
  • NUS Medical Society Outstanding Tutor Award 2018
  • SingHealth Graduation and Best Junior Doctors Award, Best House Office Award, 2015

Research Interests

Publications

  • Evelyn Yi Ting Wong1, Ming Hui Yong2, Kok Pin Yong2, Eng Huat Tan1, Chee Keong Toh1, Ravindran Kanesvaran1, Angela Takano3, Quan Sing Ng1.Author Affiliation: 1Division of Medical Oncology, Na-tional Cancer Centre Singapore,2Department of Neurology, National Neuroscience Institute - Singapore General Hospital Campus, Singapore.3Department of Anatomical Pathology, Singapore General Hospital, Singapore. Immune checkpoint inhibitor‐associated myositis and myasthenia gravis overlap: Understanding the diversity in a case series. Asia Pac J Clin Oncol. 2020 Sep 27. doi: 10.1111/ajco.13442
  • Evelyn Y.T Wong1, Grace H.C. Tan1, Claramae S.L. Chia1, Mrinal Kumar1, Melissa C.C. Teo1. Author Affiliation: 1Division of Surgical Oncology, National Cancer Center Singapore. Hematologic Toxicities after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Asia Pac J Clin Oncol. 2020 Apr;16(2):e38-e46. doi: 10.1111/ajco.13275
  • Evelyn Y.T. Wong1, Grace H.C. Tan1, Deanna W.J. Ng1, Koh P.T. Tina1, Mrinal Kumar1, Melissa C.C. Teo1. Author Affiliation: 1Divison of Surgical Oncology, National Cancer Center, Singapore Surgical Management of Metastatic Colorectal Cancer: Survival Outcomes of Pulmonary Resection vs Cy-toreductive Surgery and HIPEC. J Gastrointest Cancer 2017 Dec;48(4):353-360. doi: 10.1007/s12029-016-9895-4.
  • Evelyn Y.T Wong1, Grace H.C. Tan1, Claramae S.L. Chia, Mrinal Kumar1, Khee Chee Soo1, Melissa C.C. Teo1 Author Affiliation: 1Division of Surgical Oncology, National Cancer Center Singapore. Morbidity and Mortality of Elderly Patients following Cytoreductive Surgery and HIPEC. Asia Pac J Clin On-col. 2018 Apr;14(2):e193-e202. doi: 10.1111/ajco.12723
  • Evelyn Yi Ting Wong1, Clarinda Chua2, Sok Yuen Beh2, Dennis Koh3, Dawn Chong2 and Iain Beehuat Tan *2. Author Affliation: 1Singapore General Hospital, Singapore, Singapore2Department of Medical Oncology, National Cancer Centre, Singapore 3Department of Colorectal Surgery, Singapore General Hospital, Singapore. Expert Rev Anticancer Ther. 2015 Jun;15(6):639-48. doi: 10.1586/ 14737140.2015.1038248

Research Trials